Clinical Trial Update: The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a botulinum toxin–containing pharmaceutical composition for atrial fibrillation; ischemic heart disease listed as a related co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Ischemic Heart Disease

Drugs mentioned

• Botulinum toxin-containing pharmaceutical composition for atrial fibrillation (botulinum toxin)

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Atrial Fibrillation, Ischemic Heart Disease | Phase 2 | Status: UNKNOWN